GLASF
Price
$9.02
Change
-$0.08 (-0.88%)
Updated
Dec 24 closing price
Capitalization
722.33M
83 days until earnings call
Intraday BUY SELL Signals
GTBIF
Price
$8.14
Change
+$0.39 (+5.03%)
Updated
Dec 24 closing price
Capitalization
1.89B
Intraday BUY SELL Signals
Interact to see
Advertisement

GLASF vs GTBIF

Header iconGLASF vs GTBIF Comparison
Open Charts GLASF vs GTBIFBanner chart's image
Glass House Brands
Price$9.02
Change-$0.08 (-0.88%)
Volume$256.74K
Capitalization722.33M
Green Thumb Industries
Price$8.14
Change+$0.39 (+5.03%)
Volume$175.35K
Capitalization1.89B
GLASF vs GTBIF Comparison Chart in %
GLASF
Daily Signal:
Gain/Loss:
GTBIF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLASF vs. GTBIF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Hold and GTBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (GLASF: $9.02 vs. GTBIF: $8.14)
Brand notoriety: GLASF and GTBIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 91% vs. GTBIF: 26%
Market capitalization -- GLASF: $722.33M vs. GTBIF: $1.89B
GLASF [@Pharmaceuticals: Generic] is valued at $722.33M. GTBIF’s [@Pharmaceuticals: Generic] market capitalization is $1.89B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileGTBIF’s FA Score has 1 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • GTBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, GTBIF is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 5 TA indicator(s) are bullish while GTBIF’s TA Score has 6 bullish TA indicator(s).

  • GLASF’s TA Score: 5 bullish, 4 bearish.
  • GTBIF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GTBIF is a better buy in the short-term than GLASF.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а -5.55% price change this week, while GTBIF (@Pharmaceuticals: Generic) price change was -15.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.58%. For the same industry, the average monthly price growth was +8.11%, and the average quarterly price growth was +22.96%.

Reported Earning Dates

GLASF is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.58% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GTBIF($1.89B) has a higher market cap than GLASF($722M). GLASF has higher P/E ratio than GTBIF: GLASF (513.07) vs GTBIF (47.88). GLASF YTD gains are higher at: 55.517 vs. GTBIF (-0.367). GTBIF has higher annual earnings (EBITDA): 369M vs. GLASF (32M). GTBIF has more cash in the bank: 226M vs. GLASF (26.3M). GLASF has less debt than GTBIF: GLASF (75.3M) vs GTBIF (518M). GTBIF has higher revenues than GLASF: GTBIF (1.16B) vs GLASF (196M).
GLASFGTBIFGLASF / GTBIF
Capitalization722M1.89B38%
EBITDA32M369M9%
Gain YTD55.517-0.367-15,119%
P/E Ratio513.0747.881,072%
Revenue196M1.16B17%
Total Cash26.3M226M12%
Total Debt75.3M518M15%
FUNDAMENTALS RATINGS
GLASF vs GTBIF: Fundamental Ratings
GLASF
GTBIF
OUTLOOK RATING
1..100
686
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9688
PRICE GROWTH RATING
1..100
3741
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
2050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLASF's Valuation (93) in the null industry is in the same range as GTBIF (93). This means that GLASF’s stock grew similarly to GTBIF’s over the last 12 months.

GLASF's Profit vs Risk Rating (100) in the null industry is in the same range as GTBIF (100). This means that GLASF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's SMR Rating (88) in the null industry is in the same range as GLASF (96). This means that GTBIF’s stock grew similarly to GLASF’s over the last 12 months.

GLASF's Price Growth Rating (37) in the null industry is in the same range as GTBIF (41). This means that GLASF’s stock grew similarly to GTBIF’s over the last 12 months.

GTBIF's P/E Growth Rating (11) in the null industry is significantly better than the same rating for GLASF (100). This means that GTBIF’s stock grew significantly faster than GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASFGTBIF
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signal:
Gain/Loss:
GTBIF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THPBX24.650.05
+0.20%
BNY Mellon Balanced Opportunity J
CRBRX14.880.03
+0.20%
Columbia Acorn Inst2
LEOOX9.440.01
+0.11%
Lazard Enhanced Opportunities Open
MLRRX10.640.01
+0.09%
NYLI Winslow Large Cap Growth Class R1
DRRIX17.30N/A
N/A
BNY Mellon Global Real Return - I

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-0.88%
TSNDF - GLASF
63%
Loosely correlated
+4.46%
GTBIF - GLASF
62%
Loosely correlated
+5.03%
TCNNF - GLASF
60%
Loosely correlated
+3.32%
CURLF - GLASF
57%
Loosely correlated
-2.20%
CRLBF - GLASF
57%
Loosely correlated
+2.40%
More

GTBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with TCNNF. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBIF
1D Price
Change %
GTBIF100%
+5.03%
TCNNF - GTBIF
83%
Closely correlated
+3.32%
CURLF - GTBIF
82%
Closely correlated
-2.20%
TSNDF - GTBIF
78%
Closely correlated
+4.46%
CRLBF - GTBIF
71%
Closely correlated
+2.40%
JUSHF - GTBIF
71%
Closely correlated
-3.80%
More